Journals / Biyolojik Çeşitlilik ve Koruma / 2021 / Cilt: 14 Sayı: 1

PLANT-DERİVED VACCİNES

Bitkisel türevli aşılar

Pages
167–174
Publication Date
2021-04-15
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Plants are extremely suitable expression vectors for industrial production of pharmaceutical proteins, with their proven production capacity and economic feasibility.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Plants are platforms where recombinant proteins and other biopharmaceuticals can be produced easily, cheaply and safely and can be purified back.
📊
Key Findings & Data:Recently, many recombinant proteins such as growth hormone, antibody milk proteins, serum albumin and various industrial enzymes produced in bacterial or mammalian cell cultures have been produced in plant tissue or in plant cell culture.
💡
Conclusion & Impact:Plants are extremely suitable expression vectors for industrial production of pharmaceutical proteins, with their proven production capacity and economic feasibility.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Bitkisel aşılar · genetik modifikasyon · bitki biyoteknoloji

Abstract

Plants are platforms where recombinant proteins and other biopharmaceuticals can be produced easily, cheaply and safely and can be purified back. Recently, many recombinant proteins such as growth hormone, antibody milk proteins, serum albumin and various industrial enzymes produced in bacterial or mammalian cell cultures have been produced in plant tissue or in plant cell culture. Plant tissues provide suitable post-translational modifications for production of recombinant viral and bacterial antigens and show the same biological activity as the recombinant vaccines produced in microorganisms. All of these have paved the way for their usage in vaccine production. Production of recombinant protein in plants requires stable or transient integration of target gene sequence depending on the location in the plant cell. While the biolistic method is used for the stable transformation of the target gene in the nucleus or chloroplast, plant pathogen Agrobacterium sp. mediated gene transfer method is used for transient gene transfer. Plants are extremely suitable expression vectors for industrial production of pharmaceutical proteins, with their proven production capacity and economic feasibility.

Özet

Bitkiler, rekombinant proteinlerin ve diğer biyofarmasotiklerin kolay, ucuz ve güvenli üretiminin sağlanabildiği ve geri saflaştırılabildiği platformlardır. Günümüzde bakteri ya da memeli hücre kültürlerinde üretilen büyüme hormonu, antikor süt proteinleri, serum albumini ve çeşitli endüstriyel enzimler gibi birçok rekombinant proteinin bitkisel dokuda ya da bitki hücre kültüründe üretimi gerçekleştirilmiştir. Bitkisel dokuların rekombinant viral ve bakteriyel antijenlerin üretimleri için uygun post-translasyonel modifikasyonları sağlamaları ve mikroorganizmalarda üretilen rekombinant aşılar ile aynı biyolojik aktiviteyi göstermeleri, aşı üretiminde kullanılmalarının önünü açmıştır. Bitkisel rekombinant protein üretimi, hedef gen dizisinin bitki hücresindeki konumuna bağlı olarak stabil veya geçici entegrasyonunu gerektirir. Biyolistik yöntemi hedef genin çekirdek veya kloroplastta stabil transformasyonu için kullanılırken, bir bitki patojeni olan Agrobacterium sp. aracılı gen transferi yöntemi, geçici gen transferi için kullanılmaktadır. Bitkisel sistemler kanıtlanmış üretim kapasiteleri ve ekonomik fizibiliteleri ile farmasotik proteinlerin endüstriyel boyutta üretimleri için son derece uygun ekspresyon vektörleridir.

🔖

Cite This Article

OKAY, A., AYDIN, S. S., BÜYÜK, İ., ARAS, E. S. (2021). PLANT-DERİVED VACCİNES. Biyolojik Çeşitlilik ve Koruma, Cilt: 14 Sayı: 1, 167–174. https://ajindex.com/articles/903017

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Hamborsky, J., Kroger A., Wolfe S, eds. 13th ed. (2015) Centers for Disease Control and Prevention. Epidemiology and Prevention of Vaccine-Preventable Diseases. Washington D.C. Public Health Foundation.1,4
  2. Wang, H., Dwyer-Lindgren L., Lofgren, K. T., Rajaratnam, J. K., Marcus, J. R., Levin-Rector, A., Levitz, C. E., Lopez, A. D., & Murray, C. J. (2012). Age-specific and sex-specific mortality in 187 countries, 1970–2010: a systematic analysis for the Global Burden of Disease Study 2010. The Lancet, 380(9859), 2071-2094
  3. Ohmit, S. E., Victor, J. C., Rotthoff, J. R., Teich, E. R., Truscon, R. K., Baum, L. L., Rangarajan, B., Newton, D. W., Boulton, M. L., & Monto, A. S. (2006). Prevention of antigenically drifted influenza by inactivated and live attenuated vaccines. New England Journal of Medicine, 355(24), 2513-2522
  4. Moghaddam, A., Olszewska, W., Wang, B., Tregoning, J. S., Helson, R., Sattentau, Q. J., & P. J. Openshaw (2006). A potential molecular mechanism for hypersensitivity caused by formalin-inactivated vaccines. Nature Medicine, 12(8), 905-907
  5. Lobato, F. C., Lima, C. G., Assis, R. A., Pires, P. S., Silva, R. O., Salvarani, F. M., Carmo, A. O., Contigli, C., & Kalapothakis, E., (2010). Potency against enterotoxemia of a recombinant Clostridium perfringens type D epsilon toxoid in ruminants. Vaccine, 28(38), 6125-6127
  6. Takeyama, N., Kiyono, H. & Yuki, Y. (2015). Plant-based vaccines for animals and humans: recent advances in technology and clinical trials. Therapeutic Advances in Vaccines. 3(5-6), 139-154
  7. Hefferon, K. L. (2010). The mucosal immune response to plant-derived vaccines. Pharmaceutical Research, 27(10), 2040-2042
  8. Schillberg, S., Raven N., Spiegel, H., Rasche, S. & Buntru, M. (2019). Critical analysis of the commercial potential of plants for the production of recombinant proteins. Frontiers in Plant Science, 10, 720
  9. Daniell, H., Rai, V. & Xiao, Y. (2019). Cold chain and virus‐free oral polio booster vaccine made in lettuce chloroplasts confers protection against all three poliovirus serotypes. Plant Biotechnology Journal, 17(7), 1357-1368
  10. Mason, H. S., Lam, D. & Arntzen, C. J. (1992). Expression of hepatitis B surface antigen in transgenic plants. Proceedings of the National Academy of Sciences, 89(24), 11745-11749
  11. Tuboly, T., Yu, W., Bailey, A., Degrandis, S., Du, S., Erickson, L. & Nagy, E. (2000). Immunogenicity of porcine transmissible gastroenteritis virus spike protein expressed in plants.